OPG was shown to inhibit the development of osteolytic bone disease in MM.(19) In general, an increase in the RANKL/OPG ratio favors bone destruction.(20, 21) This is seen in inflammatory diseases such as rheumatoid arthritis and in several types of cancers. The gene discussed is TNFRSF11B; the disease is Miyoshi myopathy.